Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • alharvey17
    Junior Member
    • Sep 2023
    • 1

    #1

    GTF/Reference genome adjustments? Gene-based differential expression analysis of genetically modified mouse line

    Hello everyone,

    I am trying to analyze my bulk RNAseq data set from hippocampal tissue extracted from our WT/KO mice. The knockout consists of a 10kb deletion within a single exon of our gene of interest. I plan to use STAR --> featurecounts --> DEseq2. I want to look at differential gene expression of all genes in the dataset, but in addressing the genetic modification, I'm wondering if I should add an additional entries to the gtf annotation file (currently using gencode.vM31) or to the genome fasta (GRCm39) with the sequence of the modified exon/transcript, and if so, how to go about doing that? I'm worried the big change in length of the resulting transcript may skew the results of our gene of interest if its just assigned to the same gene/transcript ID.

    I'd be curious how the chromosome coordinates would work with that... should the new exon/transcript be its own separate custom chromosome included in the genome fasta? If so should the gtf file contain just the info on the single exon and resulting transcript coordinates on that custom chromosome or should it include the info of all the remaining exons in the gene?

    If including all unchanged exons how would the packages be able to differentiate between the resulting transcripts if those sequences are identical (except for the one modified exon)?

    Please let me know if I should include any other helpful details of the experiment!
    ​

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...